UNSPSC 51111664: Aminopterin

This classification denotes a folate antagonist and dihydrofolate reductase inhibitor with the molecular formula C19H20N8O5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier JYB41CTM2Q, chemically known as folic acid, 4-amino- but generally known as aminopterin, which bears US NIH Compound Identifier 2154. aminopterin most often comes in base, hydrate, n-hydroxysuccinimide ester, and sodium forms. European Medicines Agency schedules Aminopterin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00464MIG.

UNSPSC 51111664 Aminopterin is a Commodity code covering a specialized pharmaceutical compound used in cancer chemotherapy and certain autoimmune disorder treatments. State and local governments procure aminopterin primarily through their health departments, correctional facilities, public hospitals, and affiliated clinics to support inpatient and outpatient oncology and rheumatology services. The product is a folic acid antagonist typically supplied as a sterile injectable formulation and is subject to strict pharmaceutical licensing, cold-chain storage, and controlled-substance tracking requirements.

The source contains no recent state or local contract opportunities tagged to this code. Without posted solicitations in the recent-opportunities dataset, the geographic distribution of aminopterin procurement and the specific issuing bodies currently buying under this code cannot be characterized.